Molecular data inc. receives nasdaq notification

Shanghai , june 24, 2022  /prnewswire/ -- molecular data, inc. ("molecular data" or the "company") (nasdaq: mkd), a technology-driven platform in china, announced that it had received a letter from the nasdaq stock market llc ("nasdaq"), notifying the company that to date, it has not regained compliance with the rule 5250(c)(1). since the company is already before a hearings panel for its failure to comply with the $1.00 minimum bid price requirement set forth in listing rule 5550(a)(2),pursuant to listing rule 5810(d)(2), rather than submit a compliance plan for staff's review, the company is to address the matter before the hearings panel.
MKD Ratings Summary
MKD Quant Ranking